EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Single Institution Experience With Sinonasal Glomangiopericytoma: A Case Series

Natalie Schauwecker iD, Seth Davis, Alexander Perez, Alex Labby, Kyle Mannion, Robert Sinard iD, James S Lewis, Rick Chandra

Ear, Nose & Throat Journal · 2026

DOI: 10.1177/01455613231179688 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Ear, Nose & Throat Journal, 2026. Verfasst von Natalie Schauwecker und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, Vanderbilt University Medical Center, Nashville, TN, USA. Hauptthemen laut MEDLINE: Hemangiopericytoma, Paranasal Sinus Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Sinonasal glomangiopericytoma (GPC) is an uncommon neoplasm, accounting for less than 0.5% of all sinonasal tumors. It is characterized as having low malignant potential, with complete surgical excision representing optimal treatment. Presenting symptoms are typically due to mass effect and vascularity of this tumor, often including unilateral nasal obstruction or epistaxis. Accounts of this tumor in the literature remain sparse.

Methods

Single institution retrospective review.

Results

Six cases of sinonasal GPC were identified from a review of the electronic medical records spanning from 2009 through 2021. Age at diagnosis ranged from 48 to 67 years, with a gender distribution of 5 males and 1 female. Most subjects presented with unilateral sinonasal obstruction of variable duration. Each underwent endoscopic resection of the mass with negative margins, and no adjuvant therapy was pursued. Pathologic specimens demonstrated a vascular patterned tumor with spindled cells surrounding vessels and were positive for smooth muscle actin and negative for cytokeratin. Active post-surgical follow-up ranged from 11 months to 10 years. All patients were without endoscopic evidence of recurrence, and 2 had post-operative imaging which showed no evidence of disease.

Conclusions

This review of 6 cases of sinonasal GPC represents the largest known series of this rare pathology in the literature to date. Based on our experience, and in agreement with the available literature, this disease is reliably managed with complete surgical excision. Adjuvant therapy can be avoided in otherwise uncomplicated cases. Although rare, GPC should be considered in the differential diagnosis of all vascular sinonasal tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HemangiopericytomaParanasal Sinus NeoplasmsAgedFemaleHumansMaleMiddle AgedEndoscopyNasal ObstructionRetrospective StudiesTreatment Outcome

Stichwörter der Autor:innen

endoscopic surgeryglomangiopericytomarhinologyvascular tumor

Autor:innen und Institutionen

  • Department of Otolaryngology-Head and Neck Surgery, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.

ORCID-Profile: Natalie Schauwecker, Robert Sinard

Zitieren

APA

Schauwecker, N., Davis, S., Perez, A., Labby, A., Mannion, K., Sinard, R., Lewis, J. S., & Chandra, R. (2026). Single Institution Experience With Sinonasal Glomangiopericytoma: A Case Series. Ear, Nose & Throat Journal. https://doi.org/10.1177/01455613231179688

Vancouver

Schauwecker N, Davis S, Perez A, Labby A, Mannion K, Sinard R, et al. Single Institution Experience With Sinonasal Glomangiopericytoma: A Case Series. Ear, Nose & Throat Journal. 2026. doi:10.1177/01455613231179688

BibTeX
@article{Schauwecker2026,
  author = {Schauwecker, Natalie and Davis, Seth and Perez, Alexander and Labby, Alex and Mannion, Kyle and Sinard, Robert and Lewis, James S and Chandra, Rick},
  title = {Single Institution Experience With Sinonasal Glomangiopericytoma: A Case Series},
  journal = {Ear, Nose & Throat Journal},
  year = {2026},
  doi = {10.1177/01455613231179688}
}
Kostenlos starten →